The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

americangene.com

Founded Year

2007

Stage

Angel | Alive

Total Raised

$3.5M

About American Gene Technologies International

American Gene Technologies is developing and commercializing genetic medicines targeting major diseases, including HIV/AIDS, Phenylketonuria (PKU) and Hepatocellular carcinoma (liver cancer, or HCC).

American Gene Technologies International Headquarter Location

9640 Medical Center Drive

Rockville, Maryland, 20850,

United States

301-337-2100

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing American Gene Technologies International

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

American Gene Technologies International is included in 2 Expert Collections, including Biopharma Tech.

B

Biopharma Tech

15,535 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

C

Cancer

3,605 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

American Gene Technologies International Patents

American Gene Technologies International has filed 35 patents.

The 3 most popular patent topics include:

  • Clusters of differentiation
  • Immunology
  • Molecular biology
patents chart

Application Date

Grant Date

Title

Related Topics

Status

3/10/2021

2/8/2022

RNA, Radiation therapy, Molecular biology, Cancer treatments, Oncology

Grant

Application Date

3/10/2021

Grant Date

2/8/2022

Title

Related Topics

RNA, Radiation therapy, Molecular biology, Cancer treatments, Oncology

Status

Grant

Latest American Gene Technologies International News

American Gene Technologies International Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 12092018 Prices from USD $250

Dec 2, 2018

Printed From BioPortfolio.com American Gene Technologies International Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 12092018] Prices from USD $250 00:10 EST 2 Dec 2018 | BioPortfolio Reports Summary American Gene Technologies International Inc AGT is a drug development company that tests and commercializes genebased drugs. The company develops therapies for the treatment of cancer , neurological disorders, AIDS, infectious diseases, Parkinson's diseases, diabetes, familial dysautonomia, hepatocellular carcinoma, phenylketonuria, autosomal disorders, and other chronic human diseases. It also provides rapid drug development programs, genetic technologies and gamma delta T cell therapy, among others. AGT develops various products in the laboratory testing phase for oncology indications. The company partners with medical researchers, and pharmaceutical and biotech firms for its drug development activities. AGT is headquartered in Rockville, Maryland, the US. American Gene Technologies International Inc Pharmaceuticals Healthcare Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions MAs, partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, subsector and regions. GlobalData derived the data presented in this report from proprietary inhouse Pharma eTrack deals database, and primary and secondary research. Scope Financial Deals Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. Deals by Year Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. Deals by Type Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. Deals by Region Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. Deals by Subsector Chart and table showing information on the number of deals and value reported by the company, by subsector. Major Deals Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's major public companies key financial metrics and ratios. Business Description A brief description of the company's operations. Key Employees A list of the key executives of the company. Important Locations and Subsidiaries A list and contact details of key centers of operation and subsidiaries of the company. Key Competitors A list of the key competitors of the company. Key Recent Developments A brief on recent news about the company. Reasons to Buy Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period. Understand the company's business segments' expansion / divestiture strategy The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy. Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios. Equip yourself with detailed information about the company's operations to identify potential customers and suppliers. The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors. Stay uptodate on the major developments affecting the company Recent developments concerning the company presented in the profile help you track important events. Gain key insights into the company for academic or business research Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs. Note*: Some sections may be missing if data is unavailable for the company. Related Biotechnology, Pharmaceutical and Healthcare News

American Gene Technologies International Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

American Gene Technologies International Rank

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.